European Healthtech startup funding raised during H1 2016.
In H1 2016, 163 European Healthtech companies raised a combined €1.1B across 169 funding rounds, up 119.0% versus H1 2015. UK led by capital raised, and High-Tech Gr√ºnderfonds (HTGF) was the most active investor. Data as of 23 Aug 2026.
14 exits · €1.8B disclosed.
| Arcam | Acquisition | Feb 2016 | €636M |
| Valtech Cardio | Acquisition | Apr 2016 | €628M |
| EngMab | Acquisition | May 2016 | €545M |
| May 2016 |
| €40M |
| CRISPR Therapeutics | Series B | Jun 2016 | €35M |
| MedDay | Series B | Apr 2016 | €34M |
| Impulse Dynamics | Growth/Late | May 2016 | €30M |
| NovImmune | Series D+ | Jan 2016 | €27M |
| G-Therapeutics | Series A | Apr 2016 | €26M |
| STAT-Diagnostica | Series C | Apr 2016 | €25M |
| Babylon Health | Growth/Late | Jan 2016 | €23M |
| EarlySense | Series D+ | Jun 2016 | €23M |
| Allecra Therapeutics | Series B | Jun 2016 | €22M |
| apotea.se | Growth/Late | May 2016 | €22M |
| Cambridge Epigenetix | Series B | Mar 2016 | €19M |
